Australia markets closed

Elevation Oncology, Inc. (ELEV)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.7400+0.0400 (+1.08%)
At close: 04:00PM EDT
3.7500 +0.01 (+0.27%)
After hours: 06:46PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-39,352
-45,704
-95,080
-32,039
-17,265
Depreciation & amortisation
39
39
27
18
15
Stock-based compensation
2,773
3,335
3,206
1,571
52
Change in working capital
-13,037
-13,690
6,290
283
4,900
Accounts payable
-3,607
-5,855
711
-30
5,219
Other working capital
-48,924
-56,180
-85,569
-30,167
-12,369
Other non-cash items
698
702
285
-
-
Net cash provided by operating activities
-48,924
-56,180
-85,483
-30,167
-12,298
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-86
-
-71
Purchases of investments
-
-42,657
-112,312
0
-
Sales/maturities of investments
48,300
54,200
68,000
0
-
Net cash used for investing activities
5,643
11,543
-44,398
0
-71
Cash flows from financing activities
Common stock issued
76,159
46,503
0
97,062
20
Common stock repurchased
-38
-24
-35
0
-
Other financing activities
-
-
-470
-11
-174
Net cash used provided by (used for) financing activities
78,009
47,975
29,514
97,051
90,029
Net change in cash
34,728
3,338
-100,367
66,884
77,660
Cash at beginning of period
55,902
45,917
146,284
79,400
1,740
Cash at end of period
90,630
49,255
45,917
146,284
79,400
Free cash flow
Operating cash flow
-48,924
-56,180
-85,483
-30,167
-12,298
Capital expenditure
-
-
-86
-
-71
Free cash flow
-48,924
-56,180
-85,569
-30,167
-12,369